Advertisements


remdesivir doesn t help COVID-19 patients

remdesivir doesn t help COVID-19 patients.....»»

Category: entertainmentSource: pep pepOct 16th, 2020

Fauci says Trump’s talk of Covid-19 ‘cure’ causing confusion

US President Donald Trump has been talking up an experimental Covid-19 treatment he received as “a cure,” but one of his top government scientists said referring to it as such may cause “confusion.” Anthony Fauci, the longtime director of the National Institute of Allergies and Infectious Disease, gave an interview to CBS News on Friday where he also referred to the coronavirus outbreak at the White House that infected dozens of people as a “super spreader event.” Asked about Trump’s effusive praise for Regeneron’s antibody treatment, Fauci said that talking about a “cure” could be misleading because it hasn’t yet been proven, and the drugs that are currently available have only been shown to have modest to moderate results.  “We don’t have any indication — I think you really have to depend on what you mean by a cure, because that’s the word that leads to a lot of confusion,” he said. He then walked through some of the medicines that are currently recommended or have been temporarily approved against the disease. These include the antiviral remdesivir which has been shown to diminish time to recovery among hospitalized patients, and the steroid dexamethasone, which reduces mortality rates in patients who need supplemental oxygen. Regeneron’s treatment belongs to a class of drug called monoclonal antibodies. Fauci said that while these had been “showing promise in clinical trials,” the research is still ongoing and no final determination has been made. Fauci was also asked about the low level of mask use at the White House until recently, and what lessons could be learned. “I think the — the data speaks for themselves,” the scientist said of mask-wearing.  “We had a super-spreader event in the White House and it was in a situation where people were crowded together and were not wearing masks. So the data speak for themselves.” More than 30 people are thought to have been infected at a White House ceremony held September 26 for the nomination of Amy Coney Barrett to the Supreme Court. The president’s doctor Sean Conley has said Trump may return to public engagements as early as Saturday, raising fears that he may still have high levels of the virus in his body and therefore still be contagious.  Fauci said he had faith that the president’s medical team wouldn’t allow him to do that. “I can tell you, they are going to be testing him to determine the trajectory and whether he gets to the point where he’s not infected,” he said. “I can guarantee you that they will be testing him before they let him go out.”.....»»

Category: newsSource:  mb.com.phRelated NewsOct 9th, 2020

Late-stage study of COVID-19 convalescent-plasma treatment with remdesivir starts

A late-stage trial testing the combination of Gilead Sciences’ remdesivir and a highly concentrated solution of antibodies that neutralize the COVID-19 virus has begun, the National Institutes of Health (NIH) said on Thursday, October 8, 2020. Trial investigators believe that giving the antibody solution to COVID-19 patients at the onset of symptoms could heighten the […] The post Late-stage study of COVID-19 convalescent-plasma treatment with remdesivir starts appeared first on Cebu Daily News......»»

Category: newsSource:  inquirerRelated NewsOct 9th, 2020

Manila buys P13-M antiviral drug for city’s COVID patients

  BY MINKA TIANGCO     The Manila city government purchased 2,000 vials of remdesivir, a drug that is used to treat coronavirus disease-2019 (COVID-19) patients, the city mayor announced Thursday night. Manila Mayor Francisco “Isko Moreno” Domagoso said the antiviral drug can be used to treat almost 200 of the city’s COVID-19 patients with […].....»»

Category: newsSource:  tempoRelated NewsAug 14th, 2020

DoH warns vs Remdesivir use outside clinical trials

The Department of Health (DoH) said on Friday that COVID-19 patients who intend to use the investigational drug Remdesivir outside clinical trials should secure a “compassionate special permit” from the Food and Drug Administration (FDA). This came after the City of Manila procured P13 million-worth of 2,000 Remdesivir vials for the treatment of their COVID-19 […] The post DoH warns vs Remdesivir use outside clinical trials appeared first on Daily Tribune......»»

Category: newsSource:  tribuneRelated NewsAug 14th, 2020

Remdesivir shows ‘positive effects’ on COVID-19 patients but not conclusive

  MANILA, Philippines — The antiviral drug remdesivir which is being eyed as a treatment for the coronavirus disease 2019 (COVID-19) has so far shown “positive effects” on some patients taking it. However, such findings are not conclusive yet, the Department of Health (DOH) said Thursday. Health Undersecretary Maria Rosario Vergeire said some patients taking […] The post Remdesivir shows ‘positive effects’ on COVID-19 patients but not conclusive appeared first on Cebu Daily News......»»

Category: newsSource:  inquirerRelated NewsJul 2nd, 2020

Singapore okays remdesivir drug for COVID cure

Singapore---Singapore has approved the use of the anti-viral drug remdesivir to treat seriously ill coronavirus patients, authorities said Wednesday, becoming the latest country to do so......»»

Category: newsSource:  thestandardRelated NewsJun 10th, 2020

117 Pinoy COVID patients kasali sa solidarity trial ng isang gamot

MAY 117 coronavirus disease 2019 patients sa bansa na sumali sa World Health Organization Solidarity Trial para sa gamot na Remdesivir. Ang mga pasyente ay nasa 14 na ospital sa National Capital Region at isa sa Davao. Ikinatuwa naman ni San Jose Del Monte City Rep. Florida Robes ang paglahok ng Department of Health at […] The post 117 Pinoy COVID patients kasali sa solidarity trial ng isang gamot appeared first on Bandera......»»

Category: newsSource:  inquirerRelated NewsJun 4th, 2020

Remdesivir, posibleng maaprubahan sa Japan ngayong linggo: health minister

Japan – Posibleng aprubahan sa Japan ang antiviral drug na remdesivir ng Gilead Sciences Inc para sa mga domestic COVID-19 patients, ayon kay Japanese Health Minister Katsunobu Kato. “Once imported, we would like to have it used by those who are suffering from serious conditions as soon as possible,” ani Kato. Maaalalang pinalawig ni Prime […] The post Remdesivir, posibleng maaprubahan sa Japan ngayong linggo: health minister appeared first on REMATE ONLINE......»»

Category: newsSource:  remateRelated NewsMay 6th, 2020

First anti-COVID-19 drug approved in US

  THE United States Food and Drug Administration (FDA) approved last Friday the emergency use of a new drug – remdesivir – that appeared to have shortened the recovery time of COVID-19 patients from 15 to 11 days on average. The study is ongoing and not yet large enough and the scientists are not ready […].....»»

Category: newsSource:  tempoRelated NewsMay 4th, 2020

Remdesivir: The COVID-19 drug helping patients recover faster

Remdesivir has been shown to speed up recovery times for patients with COVID-19 in a major US-led trial, becoming the first drug with proven benefit against the disease......»»

Category: newsSource:  thestandardRelated NewsMay 1st, 2020

Antiviral drug hastens recovery

COVID-19 patients who took the antiviral remdesivir recovered about 30 percent faster than those on a placebo, the results of a major clinical trial showed Wednesday, as the top US epidemiologist hailed the drug’s “clear-cut” benefit......»»

Category: newsSource:  thestandardRelated NewsMay 1st, 2020

Experimental virus drug Remdesivir effective in monkeys

The experimental antiviral drug Remdesivir has proven effective against COVID-19 in a small experiment involving monkeys, US government scientists reported Friday. The study, which is preliminary and has not yet been peer-reviewed, was designed to follow dosing and treatment procedures used for hospitalized COVID-19 patients in a large human trial. It involved two groups of […] The post Experimental virus drug Remdesivir effective in monkeys appeared first on Daily Tribune......»»

Category: newsSource:  tribuneRelated NewsApr 18th, 2020

Makati Medical Center says a quarter of its COVID-19 patients recovered

"This isn't a seal of death. Just because you have COVID-19 doesn't mean that's your final death sentence," MMC medical director Saturnino Javier said in a radio interview......»»

Category: newsSource:  philstarRelated NewsMar 31st, 2020

Baeby Baste hirap din sa online classes; miss na miss na ang EB Dabarkads

KUNG may isang wish na palaging ipinagdarasal ng “Eat Bulaga” Dabarkads na si Baeby Baste, yan ay ang matapos na ang COVID-19 pandemic. Bukod sa hiling niyang paggaling ng mga COVID patients at pagiging normal muli ng buhay ng bawat Pinoy, nais niyang matapos na ang health crisis dahil miss na miss na rin ni […] The post Baeby Baste hirap din sa online classes; miss na miss na ang EB Dabarkads appeared first on Bandera......»»

Category: newsSource:  inquirerRelated News11 hr. 30 min. ago

PRC resumes swab testing, wants P.5 billion in 3 days

The Philippine Red Cross yesterday said the Philippine Health Insurance Corp. has about three days to pay the remaining P.5 billion it owes PRC for COVID-19 testing, a day after it agreed to resume testing services for the government and PhilHealth-covered patients......»»

Category: newsSource:  philstarRelated News21 hr. 47 min. ago

RAFI RESTART Webinar Series Episode 9 centers on cancer treatment and care amidst COVID-19

The pandemic has brought the world to a standstill especially the healthcare systems. Nonetheless, this should not delay patients, mainly the immunocompromised like cancer patients from seeking medical care. In celebration of the Breast Cancer Awareness Month, the Eduardo J. Aboitiz Cancer Center of the Ramon Aboitiz Foundation, Inc. (RAFI EJACC) continues to center its […] The post RAFI RESTART Webinar Series Episode 9 centers on cancer treatment and care amidst COVID-19 appeared first on Cebu Daily News......»»

Category: newsSource:  inquirerRelated NewsOct 27th, 2020

Cebu City to release cash incentives for medical frontliners this Oct. 29

CEBU CITY, Philippines — Cebu City Mayor Edgardo Labella on Monday, October 26, announced that they would start releasing the cash incentives they promised to healthcare workers attending to coronavirus disease 2019 (COVID-19) patients here. Labella, in a press conference, said the city would be distributing P10,000 to each qualified beneficiary this Thursday, October 29, […] The post Cebu City to release cash incentives for medical frontliners this Oct. 29 appeared first on Cebu Daily News......»»

Category: newsSource:  inquirerRelated NewsOct 26th, 2020

DOH to study Ebola drug vs COVID-19

The Department of Health is conducting an independent assessment on the possible use of anti-Ebola drug Remdesivir for treating coronavirus disease in the country......»»

Category: newsSource:  philstarRelated NewsOct 25th, 2020

Leyte lab charges cheap virus tests

PALO, Leyte — A private COVID testing laboratory in Tacloban is charging the local government units (LGU) of the province only P1,000 on the first test and lesser amount in subsequent tests. The low rate easily affords the LGU to require the reswabbing of recovered COVID-19 patients before they are sent home. Former energy secretary […] The post Leyte lab charges cheap virus tests appeared first on Daily Tribune......»»

Category: newsSource:  tribuneRelated NewsOct 25th, 2020

Coke PH expands Balik Pinas program for repatriated OFWs

Coca-Cola Beverages Philippines, Inc. (CCBPI)—the bottling arm of Coca-Cola in the country—has expanded its Balik Pinas program to national scale to reach more repatriated overseas Filipino workers (OFWs) and help them start their own business at home. Gareth McGeown, CCBPI President and CEO. “Coca-Cola’s commitment to Filipinos has only grown stronger, in weathering this crisis together,” said Gareth McGeown, CCBPI President and CEO. “We will help and support where we can. Through Balik Pinas, our goal is to help repatriated OFWs who have lost their livelihood abroad to start anew, via owning and operating their own business and be successful here, at home, with their families.” With the help of the Department of Labor and Employment (DOLE), CCBPI aims to reach more OFWs who are interested to start their own business through Balik Pinas. Data from the Department of Foreign Affairs show that as of September 2020, over 190,000 overseas Filipino workers have been repatriated. Balik Pinas gives opportunities to OFWs to be part of the Coca-Cola family as a distributor, wholesaler, or a community reseller. Balik Pinas is a journey that the company and new entrepreneurs take together at every step—from setting up the business, to sustaining it, to ensuring growth. Coca-Cola assists former OFWs in choosing a suitable business model for their area, helps in managing their cash flow and inventory, and sees to it that they are given proper guidance and training until they are fully ready and equipped to operate on their own—all in all, a sustainable and profitable business founded on practical support from a global beverage brand. According to Carlos Rivera, CCBPI Territory Sales Team in Naga City, the Balik Pinas Program started as a small-scale initiative in Naga City to help former OFWs. Just a couple of months after returning home, Carlos Manzano and his family was able to set up their business as Coca-Cola distributor through the Balik Pinas Program, which Carlos said has reshaped his life and outlook forever. IN PHOTO: Carlos and their family’s multi-cab routing unit with the Coca-Cola Naga Sales team. When the program’s pilot rollout started, the Manzanos—brothers Carlos and Jazz, and their father Lito—were among the pioneer members. Carlos and Jazz had both been working for several years in Qatar until the COVID-19 pandemic shook the trajectory of their career and, consequently, the well-being of their families. Together with their father, Lito, who also used to be an overseas worker, they set up a beverage distribution business in their hometown Naga City. Their optimism, as with any new business venture, was tempered with anxiety over how it would all turn out—especially with the considerable challenge of launching during such tenuous times until Rivera offered them membership to the Balik Pinas Program of Coca-Cola. Now, the Manzanos are running a profitable business as Coca-Cola distributors. “Even when I had to leave Qatar suddenly because of the lay-offs, I always envisioned that I would head back to work there when things settle. But with Coca-Cola’s Balik Pinas, I have a livelihood that doesn’t take me away from my family as being an OFW had,” said Carlos.  Lito can still remember his first order of 60 cases of Coke products. Now, the Manzano  family business has grown to an average of 4,000 cases a month, just five months after they started—a feat magnified for it being in the middle of a pandemic and strict quarantine measures. The Manzanos have also since invested in routing units to augment their business’s capabilities—a multicab and a tricycle. Since starting his business in 2019, Billy Belleza (left), is now one of the prominent Coca-Cola distributors in his area and has added another mini truck to serve more routes and deliveries. Billy is one of the pioneers of Coca-Cola’s Balik Pinas program. Another Balik Pinas program pioneer member is Billy Belleza who decided to return to the country after working for 20 years in Brunei. “I am really thankful that Coca-Cola reached out to me to be a part of this. They have never failed to present opportunities for me and my business to grow since I decided to take part in the Balik Pinas Program. My sales actually soared this year,” said Belleza, who is also based in Naga City. According to Rivera, Balik Pinas Program was really designed for returning OFWs like Billy, Carlos, and Jazz and their families to set up and run a viable business at home. “With their success and in light of current events, this program was expanded to operate on a national scale, so the company can lend assistance to repatriated OFWs and their families as they weather through new challenges brought on by the pandemic,” Rivera said. Coca-Cola has consistently sought to create programs to support MSMEs, more so now with the COVID-19 pandemic having disrupted countless lives and livelihoods. With programs like Balik Pinas, Coca-Cola remains firm in their commitment to help local communities, contributing to the restart of the national economy—by way of reaching out to Filipinos.  To know more about the program, you may reach Coca-Cola’s contact center at (02)-8813-COKE (2653). For SMART/PLDT users: toll-free number: 1800-1888-COKE (2653); and for GLOBE users: toll-free number: 1800-8888-COKE (2653). You may also contact 0919-160-COKE (2653) via SMS......»»

Category: lifestyleSource:  abscbnRelated NewsOct 24th, 2020